Why Delcath Systems, Inc.’s (DCTH) Stock Is Up 5.79%
As of Monday, August 10, Delcath Systems, Inc.’s DCTH share price has surged by 5.79%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Delcath Systems, Inc. (DCTH)
Delcath Systems, Inc. DCTH
$17.14
0.39
2.33%
August 21, 2026 4:00:00 PM
EST
Volume: 509,058
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
Commentary & Analysis
Why Delcath Systems, Inc.’s (DCTH) Stock Is Up 17.74%
As of Thursday, August 06, Delcath Systems, Inc.’s DCTH share price has surged by 17.74%, which has investors questioning if this is right time to sell.Michael Rose
Why Delcath Systems, Inc.’s (DCTH) Stock Is Up 19.17%
As of Thursday, August 06, Delcath Systems, Inc.’s DCTH share price has surged by 19.17%, which has investors questioning if this is right time to sell.Tudor Pop
Why Delcath Systems, Inc.’s (DCTH) Stock Is Up 5.16%
As of Monday, August 03, Delcath Systems, Inc.’s DCTH share price has surged by 5.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Delcath Systems, Inc.’s (DCTH) Stock Is Down 5.21%
As of Friday, July 10, Delcath Systems, Inc.’s DCTH share price has dipped by 5.21%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | DCTH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $581.6 | $407.7 | 38% |
|
| Shares Out (Mil) | 39.8 | 41.3 | 42% |
|
| Institutional Ownership | 84.3% | 81.4% | 52% |
|
| Float (Mil) | 28.8 | 34.9 | 35% |
|
| Beta | na | 0.88 | na |
|
| Avg Daily Volume (000s) | 798 | 412 | 66% |
|
| Price Change (52-week) |
58.7% | 64.8% | 82% |
|
| Growth | DCTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 121.4% | 11.8% | 99% |
|
| Net Income (5yr) | 16.1% | (6.0%) | 66% |
|
| EPS (5yr) | 15.0% | 10.4% | 56 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (45.4%) | (16.2%) | 9% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | ($0.070) | ($0.135) | $0.045 | |
| Month Ago EPS | ($0.208) | ($0.605) | ($0.510) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.216) | ($0.634) | ($0.452) | |
| Year/Year Chg | (200.0%) | (292.9%) | 364.3% | |
| Financials | DCTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $95 | $119 | 26% |
|
| Net Income (TTM) (Mil) | $1 | ($9) | 40% |
|
| EPS (TTM) | $0.015 | ($0.400) | 40% |
|
| Operating Cash Flow (TTM) (Mil) | $20 | ($3) | 41% |
|
| Net Cash Flow (TTM) (Mil) | $13 | $1 | 59% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $21 | 20% |
|
| Enterprise Value (Q1) (Mil) | na | $427 | na |
|
| Valuation | DCTH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.79 | 3.06 | 77% |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | DCTH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 87.1% | 58.9% | 92% |
|
| Net Margin | 0.6% | (6.9%) | 33% |
|
| ROA | 0.4% | (12.7%) | 41% |
|
| ROE | 0.5% | (13.1%) | 36% |
|
| Liabilities to Assets | 11.6% | 46.0% | 7% |
|
| F-Score | 5 | 4 | 50% |
|
Delcath Systems, Inc. did not pass any screens on 8/20/2026.
